Brooks Laboratories Market Cap ($17.75M USD)
Brooks Laboratories Market Cap ($17.75M USD). As of Oct. 6, 2026, Brooks Laboratories (BROOKS) market capitalisation is ₹159.78 Cr ($17.75M), with 2.68 Cr shares outstanding at a current price of ₹59.66 on NSE, ranking 2740 out of 5368 companies by market cap in our screener. Brooks Laboratories operates in the Healthcare sector and is classified as a Small Cap stock. Examine BROOKS earnings report for recent quarterly revenue, profit and EPS trends.
Market Cap History of Brooks Laboratories (Last 10 Years)
BROOKS market capitalisation from year-end NSE closing prices over the last 10 years. Compare with Brooks Laboratories value estimation to assess whether the stock is under or overvalued.
End of Year Market Cap History — Brooks Laboratories
BROOKS year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see Brooks Laboratories screener.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹159.78 Cr
$17.75M USD
|
₹59.66 | NSE | -25.56% |
| 2025 |
₹214.63 Cr
$23.85M USD
|
₹80.14 | NSE | -56.67% |
| 2024 |
₹495.33 Cr
$55.04M USD
|
₹184.95 | BSE | +28.39% |
| 2023 |
₹385.79 Cr
$42.87M USD
|
₹144.05 | BSE | +33.02% |
| 2022 |
₹290.02 Cr
$32.22M USD
|
₹108.29 | BSE | +9.57% |
| 2021 |
₹264.68 Cr
$29.41M USD
|
₹98.83 | BSE | +50.17% |
| 2020 |
₹176.25 Cr
$19.58M USD
|
₹65.81 | BSE | +128.35% |
| 2019 |
₹77.19 Cr
$8.58M USD
|
₹28.82 | BSE | -51.85% |
| 2018 |
₹160.32 Cr
$17.81M USD
|
₹59.86 | BSE | -46.89% |
| 2017 |
₹301.83 Cr
$33.54M USD
|
₹112.70 | BSE | -14.94% |
| 2016 |
₹354.86 Cr
$39.43M USD
|
₹132.50 | BSE | +45.03% |
| 2015 |
₹244.68 Cr
$27.19M USD
|
₹91.36 | BSE | +105.26% |
| 2014 |
₹119.21 Cr
$13.25M USD
|
₹44.51 | BSE | +125.25% |
| 2013 |
₹52.92 Cr
$5.88M USD
|
₹19.76 | BSE | -10.10% |
| 2012 |
₹58.87 Cr
$6.54M USD
|
₹21.98 | BSE | +73.34% |
| 2011 |
₹33.96 Cr
$3.77M USD
|
₹12.68 | BSE | - |